FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Paul Elson

Research Profile

Disorders

Concepts & Ideas

Procedures

Antineoplastic Combined Chemotherapy Protocols

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Ahmed Abd El-Latif; Paul Elson; Amr Fergany; Katherine E Watts; Donna E Hansel
The sensitivity of initial transurethral resection or biopsy of bladder tumor(s) for detecting bladder cancer variants on radical cystectomy.
Pierre L Triozzi; Raymond Tubbs; Susan Achberger; Wayne Aldrich; Charles V Biscotti; Paul Elson; Arun D Singh
Elevated blood β-2 microglobulin is associated with tumor monosomy-3 in patients with primary uveal melanoma.
Alireza Mohammad Mohammadi; Gennady Neyman; Pablo F Recinos; John H Suh; Michael A Vogelbaum; Robert J Weil; Gene H Barnett; Samuel T Chao; Paul Elson; Nicholas F Marko; Lilyana Angelov
Role of Gamma Knife surgery in patients with 5 or more brain metastases.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Paul Elson (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Ahmed Abd El-Latif; Paul Elson; Amr Fergany; Katherine E Watts; Donna E Hansel
The sensitivity of initial transurethral resection or biopsy of bladder tumor(s) for detecting bladder cancer variants on radical cystectomy.
The Journal of urology 2013;189(4):1263-7.
2013: Pierre L Triozzi; Raymond Tubbs; Susan Achberger; Wayne Aldrich; Charles V Biscotti; Paul Elson; Arun D Singh
Elevated blood β-2 microglobulin is associated with tumor monosomy-3 in patients with primary uveal melanoma.
Melanoma research 2013;23(1):1-7.
2012: Alireza Mohammad Mohammadi; Gennady Neyman; Pablo F Recinos; John H Suh; Michael A Vogelbaum; Robert J Weil; Gene H Barnett; Samuel T Chao; Paul Elson; Nicholas F Marko; Lilyana Angelov
Role of Gamma Knife surgery in patients with 5 or more brain metastases.
Journal of neurosurgery 2012;117 Suppl():5-12.
2012: Di Sun; Ash Alizadeh; Jennifer Bates; Edward Copelan; Steven Coutre; Marc Earl; Paul Elson; Matt Kalaycio; Michaela Liedtke; Bruno C Medeiros; Mikkael A Sekeres; Ronald Sobecks; Anjali S Advani
Absolute lymphocyte count at day 28 independently predicts event-free and overall survival in adults with newly diagnosed acute lymphoblastic leukemia.
American journal of hematology 2012;87(10):957-60.
2012: Pierre L Triozzi; Susan Achberger; Wayne Aldrich; Paul Elson; Jorge Garcia; Robert Dreicer
Differential immunologic and microRNA effects of 2 dosing regimens of recombinant human granulocyte/macrophage colony stimulating factor.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2012;35(7):587-94.
2012: Brian I Rini; Mohammed Salem; Shetal Shah; Andrew Stephenson; Laura Wood; Robert Dreicer; Paul Elson; Amr Fergany; Jorge Garcia; Michael Gong; Jihad Kaouk; Eric Klein; Venkatesh Krishnamurthi; John C Rabets; Steven Campbell
The effect of sunitinib on primary renal cell carcinoma and facilitation of subsequent surgery.
The Journal of urology 2012;187(5):1548-54.
2012: Jenny J Kim; Brian I Rini; Susan A J Vaziri; Robert Wirka; Robert Dreicer; Paul Elson; Mahrukh K Ganapathi; Jorge A Garcia; Ram Ganapathi
Association of VEGF and VEGFR2 single nucleotide polymorphisms with hypertension and clinical outcome in metastatic clear cell renal cell carcinoma patients treated with sunitinib.
Cancer 2012;118(7):1946-54.
2012: Fabiola Traina; Valeria Visconte; Anjali S Advani; Edward Copelan; Hien K Duong; Paul Elson; Yingchun Han; Fred H Hsieh; Anna Jankowska; Matt Kalaycio; Reuben Kapur; Alan E Lichtin; Jaroslaw P Maciejewski; Hideki Makishima; Raghuveer Singh Mali; Christine L O'Keefe; Sara T Olalla Saad; Mikkael A Sekeres; Ramon Tiu
Single nucleotide polymorphism array lesions, TET2, DNMT3A, ASXL1 and CBL mutations are present in systemic mastocytosis.
PloS one 2012;7(8):e43090.
2011: Taolin Yi; Thomas G Budd; Paul Elson; Emese Hollovary; Barbara Jacobs; Masato Mitsuhashi; Timothy Spiro; Pierre Triozzi; Ernest C Borden
Phosphatase inhibitor, sodium stibogluconate, in combination with interferon (IFN) alpha 2b: phase I trials to identify pharmacodynamic and clinical effects.
Oncotarget 2011;2(12):1155-64.
2011: Mary K Samplaski; Paul Elson; Warren Heston; Cristina Magi-Galluzzi; Donna E Hansel
Folate hydrolase (prostate-specific membrane [corrected] antigen) 1 expression in bladder cancer subtypes and associated tumor neovasculature.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2011;24(11):1521-9.
2011: Manuel G Afable; Michael Clemente; Paul Elson; Matt Kalaycio; Alan E Lichtin; Hideki Makishima; Christine L O'Keefe; Mikkael A Sekeres; Mohammed Shaik; Yuka Sugimoto; Ramon Tiu; Anjali Advani; Jaroslaw P Maciejewski
Efficacy of rabbit anti-thymocyte globulin in severe aplastic anemia.
Haematologica 2011;96(9):1269-75.
2011: Anita Schwandt; Pierre Triozzi; Jeanie Wyckhouse; Ming Zhou; Robert Dreicer; Paul Elson; James H Finke; Jorge A Garcia; Joanna Ireland; Brian I Rini
Clinical and immunomodulatory effects of celecoxib plus interferon-alpha in metastatic renal cell carcinoma patients with COX-2 tumor immunostaining.
Journal of clinical immunology 2011;31(4):690-8.
2011: Anjali Advani; Sarah Gibson; Elizabeth Douglas; Julia Diacovo; Paul Elson; Matt Kalaycio; Edward A Copelan; Mikkael A Sekeres; Ronald Sobecks; Shawnda Sungren; Anand S Lagoo; David A Rizzieri; Eric D Hsi
Histone H4 acetylation by immunohistochemistry and prognosis in relapsed acute lymphocytic leukaemia (ALL).
British journal of haematology 2011;153(4):504-7.
2011: Ernest C Borden; Barbara Jacobs; Emese Hollovary; Lisa Rybicki; Paul Elson; Thomas Olencki; Pierre L Triozzi
Gene regulatory and clinical effects of interferon β in patients with metastatic melanoma: a phase II trial.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2011;31(5):433-40.
2011: Ramon Tiu; Lukasz Gondek; Christine L O'Keefe; Paul Elson; Jungwon Huh; Azim Mohamedali; Austin Kulasekararaj; Anjali Advani; Ronald Paquette; Alan F List; Mikkael A Sekeres; A MICHAEL MCDEVITT; Ghulam J Mufti; Jaroslaw P Maciejewski
Prognostic impact of SNP array karyotyping in myelodysplastic syndromes and related myeloid malignancies.
Blood 2011;117(17):4552-60.
2011: Cristina Magi-Galluzzi; Toyonori Tsusuki; Paul Elson; Kelly Simmerman; Chris LaFargue; Raquel Esgueva; Eric Klein; Mark A Rubin; Ming Zhou
TMPRSS2-ERG gene fusion prevalence and class are significantly different in prostate cancer of Caucasian, African-American and Japanese patients.
The Prostate 2011;71(5):489-97.
2011: Manmeet S Ahluwalia; Carol Patton; Glen Stevens; Tanya Tekautz; Lilyana Angelov; Michael A Vogelbaum; Robert J Weil; Sam Chao; Paul Elson; John H Suh; Gene H Barnett; David M Peereboom
Phase II trial of ritonavir/lopinavir in patients with progressive or recurrent high-grade gliomas.
Journal of neuro-oncology 2011;102(2):317-21.
2011: Naveen S Basappa; Paul Elson; Ali-Reza Golshayan; Laura Wood; Jorge A Garcia; Robert Dreicer; Brian I Rini
The impact of tumor burden characteristics in patients with metastatic renal cell carcinoma treated with sunitinib.
Cancer 2011;117(6):1183-9.
2011: Jorge A Garcia; Thomas E Hutson; Dale Shepard; Paul Elson; Robert Dreicer
Gemcitabine and docetaxel in metastatic, castrate-resistant prostate cancer: results from a phase 2 trial.
Cancer 2011;117(4):752-7.
2011: Jorge A Garcia; Tarek Mekhail; Paul Elson; Pierre L Triozzi; Cheryl Nemec; Robert Dreicer; Ronald M Bukowski; Brian I Rini
Clinical and immunomodulatory effects of bevacizumab and low-dose interleukin-2 in patients with metastatic renal cell carcinoma: results from a phase II trial.
BJU international 2011;107(4):562-70.
2011: Erin S Murphy; Gene H Barnett; Michael A Vogelbaum; Gennady Neyman; Glen H J Stevens; Bruce Howard Cohen; Paul Elson; Andrew D Vassil; John H Suh
Long-term outcomes of Gamma Knife radiosurgery in patients with vestibular schwannomas.
Journal of neurosurgery 2011;114(2):432-40.
2011: Lihong Yin; Paul Elson; Michael Ittmann; Pravin Rao; Jianghua Wang; Warren D W Heston
Role of TMPRSS2-ERG gene fusion in negative regulation of PSMA expression.
PloS one 2011;6(6):e21319.
2010: Amanda Fader; Nabila Rasool; Susan A J Vaziri; Toshiyuki Kozuki; Pieter W Faber; Paul Elson; Charles V Biscotti; Chad Michener; Peter G Rose; Luis A Rojas-Espaillat; Jerome L Belinson; Mahrukh K Ganapathi; Ram Ganapathi
CCL2 expression in primary ovarian carcinoma is correlated with chemotherapy response and survival outcomes.
Anticancer research 2010;30(12):4791-8.
2010: Ivan N Zama; Thomas E Hutson; Paul Elson; James M Cleary; Toni K Choueiri; Daniel Y C Heng; Nikhil Ramaiya; M Dror Michaelson; Jorge A Garcia; Jennifer J Knox; Bernard Escudier; Brian I Rini
Sunitinib rechallenge in metastatic renal cell carcinoma patients.
Cancer 2010;116(23):5400-6.
2010: Jorge A Garcia; Thomas E Hutson; Paul Elson; C Lance Cowey; Timothy Gilligan; Cheryl Nemec; Robert Dreicer; Ronald M Bukowski; Brian I Rini
Sorafenib in patients with metastatic renal cell carcinoma refractory to either sunitinib or bevacizumab.
Cancer 2010;116(23):5383-90.
2010: Juan Barbastefano; Jorge A Garcia; Paul Elson; Laura S Wood; Brian R Lane; Robert Dreicer; Steven C Campbell; Brian I Rini
Association of percentage of tumour burden removed with debulking nephrectomy and progression-free survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy.
BJU international 2010;106(9):1266-9.
2010: Robert Wesolowski; David M Peereboom; Patricia Weiss; Paul Elson; George Thomas Budd
Phase I trial of weekly docetaxel, weekly doxorubicin, daily oral cyclophosphamide, and G-CSF (ConTAC regimen) in advanced malignancies.
Investigational new drugs 2010;28(4):502-8.
2010: Richard Kim; Raymond Tsao; Ann Tan; Mike Byrne; Khaldoun Almhanna; Aleksander Lazaryan; Paul Elson; Robert Pelley
A single institution review of adjuvant therapy outcomes for resectable pancreatic adenocarcinoma: outcome and prognostic indicators.
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2010;14(7):1159-69.
2010: David M Peereboom; Dale R Shepard; Manmeet S Ahluwalia; Cathy J Brewer; Neeraj Agarwal; Glen H J Stevens; John H Suh; Steven Toms; Michael A Vogelbaum; Robert J Weil; Paul Elson; Gene H Barnett
Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme.
Journal of neuro-oncology 2010;98(1):93-9.
2010: Richard Kim; Galal El-Gazzaz; Ann Tan; Paul Elson; Michael Byrne; Young Doo Chang; Federico Aucejo
Safety and feasibility of using sorafenib in recurrent hepatocellular carcinoma after orthotopic liver transplantation.
Oncology 2010;79(1-2):62-6.
2009: Ming Zhou; Ximing J Yang; Jose I Lopez; Rajal B Shah; Ondrej Hes; Steven S Shen; Rongshan Li; Yu Yang; Fan Lin; Paul Elson; Linda Sercia; Cristina Magi-Galluzzi; Raymond Tubbs
Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.
The American journal of surgical pathology 2009;33(12):1840-9.
2009: Bill G Richendollar; Raymond E Tsao; Paul Elson; Tao Jin; Roxanne Steinle; Brad Pohlman; Eric D Hsi
Predictors of outcome in post-transplant lymphoproliferative disorder: an evaluation of tumor infiltrating lymphocytes in the context of clinical factors.
Leukemia & lymphoma 2009;50(12):2005-12.
2009: Ramon Tiu; Lukasz Gondek; Christine L O'Keefe; Jungwon Huh; Mikkael A Sekeres; Paul Elson; A MICHAEL MCDEVITT; Xiao Fei Wang; Mark Levis; Judith E Karp; Anjali Advani; Jaroslaw P Maciejewski
New lesions detected by single nucleotide polymorphism array-based chromosomal analysis have important clinical impact in acute myeloid leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(31):5219-26.
2009: Brian I Rini; Jorge A Garcia; Matthew M Cooney; Paul Elson; Allison Tyler; Kristi Beatty; Joseph Bokar; Tarek Mekhail; Ronald M Bukowski; G Thomas Budd; Pierre L Triozzi; Ernest Borden; Percy Ivy; Helen X Chen; Afshin Dolwati; Robert Dreicer
A phase I study of sunitinib plus bevacizumab in advanced solid tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(19):6277-83.
2009: Sanjay Anand; Golara Honari; Tayyaba Hasan; Paul Elson; Edward V Maytin
Low-dose methotrexate enhances aminolevulinate-based photodynamic therapy in skin carcinoma cells in vitro and in vivo.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(10):3333-43.
2009: D R Shepard; Robert Dreicer; J Garcia; Paul Elson; Cristina Magi-Galluzzi; D Raghavan; A J Stephenson; Eric A Klein
Phase II trial of neoadjuvant nab-paclitaxel in high risk patients with prostate cancer undergoing radical prostatectomy.
The Journal of urology 2009;181(4):1672-7; discussion 1677.
2009: Ali-Reza Golshayan; Saby George; Daniel Y Heng; Paul Elson; Laura S Wood; Tarek Mekhail; Jorge A Garcia; Hakan Aydin; Ming Zhou; Ronald M Bukowski; Brian I Rini
Metastatic sarcomatoid renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(2):235-41.
2009: Mikkael A Sekeres; Paul Elson; Matt Kalaycio; Anjali S Advani; Edward A Copelan; Stefan Faderl; Hagop M Kantarjian; Elihu Estey
Time from diagnosis to treatment initiation predicts survival in younger, but not older, acute myeloid leukemia patients.
Blood 2009;113(1):28-36.
2008: Ila Tamaskar; Tarek Mekhail; Robert Dreicer; Thomas Olencki; S Roman; Paul Elson; Ronald M Bukowski
Phase I trial of weekly docetaxel and daily temozolomide in patients with metastatic disease.
Investigational new drugs 2008;26(6):553-9.
2008: James H Finke; Brian I Rini; Joanna Ireland; Patricia Rayman; Amy Richmond; Ali-Reza Golshayan; Laura Wood; Paul Elson; Jorge Garcia; Robert Dreicer; Ronald Bukowski
Sunitinib reverses type-1 immune suppression and decreases T-regulatory cells in renal cell carcinoma patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(20):6674-82.
2008: Brian I Rini; Toni K Choueiri; Paul Elson; Mohamad K Khasawneh; Claudiu Cotta; Jaya Unnithan; Laura Wood; Tarek Mekhail; Jorge Garcia; Robert Dreicer; Ronald M Bukowski
Sunitinib-induced macrocytosis in patients with metastatic renal cell carcinoma.
Cancer 2008;113(6):1309-14.
2008: Saby George; Thomas E Hutson; Tarek Mekhail; Laura Wood; James Finke; Paul Elson; Robert Dreicer; Ronald M Bukowski
Phase I trial of PEG-interferon and recombinant IL-2 in patients with metastatic renal cell carcinoma.
Cancer chemotherapy and pharmacology 2008;62(2):347-54.
2008: Jorge A Garcia; Eric A Klein; Cristina Magi-Galluzzi; Paul Elson; Pierre Triozzi; Robert Dreicer
Clinical and biological effects of neoadjuvant sargramostim and thalidomide in patients with locally advanced prostate carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(10):3052-9.
2008: Ila Tamaskar; Ronald Bukowski; Paul Elson; A G Ioachimescu; Laura Wood; Robert Dreicer; Tarek Mekhail; J Garcia; Brian I Rini
Thyroid function test abnormalities in patients with metastatic renal cell carcinoma treated with sorafenib.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(2):265-8.
2008: Toni K Choueiri; Anne Plantade; Paul Elson; Sylvie Negrier; Alain Ravaud; Stéphane Oudard; Ming Zhou; Brian I Rini; Ronald M Bukowski; Bernard Escudier
Efficacy of sunitinib and sorafenib in metastatic papillary and chromophobe renal cell carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(1):127-31.
2008: Ila Tamaskar; Jorge A Garcia; Paul Elson; Laura Wood; Tarek Mekhail; Robert Dreicer; Brian I Rini; Ronald M Bukowski
Antitumor effects of sunitinib or sorafenib in patients with metastatic renal cell carcinoma who received prior antiangiogenic therapy.
The Journal of urology 2008;179(1):81-6; discussion 86.
2007: Todd W Kelley; Brad Pohlman; Paul Elson; Eric D Hsi
The ratio of FOXP3+ regulatory T cells to granzyme B+ cytotoxic T/NK cells predicts prognosis in classical Hodgkin lymphoma and is independent of bcl-2 and MAL expression.
American journal of clinical pathology 2007;128(6):958-65.
2007: Toni K Choueiri; Jorge A Garcia; Paul Elson; Mohamad Khasawneh; Saif Usman; Ali-Reza Golshayan; Rachid Baz; Laura Wood; Brian I Rini; Ronald M Bukowski
Clinical factors associated with outcome in patients with metastatic clear-cell renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy.
Cancer 2007;110(3):543-50.
2007: Zhenwen Zhao; Yijin Xiao; Paul Elson; Haiyan Tan; Sarah J Plummer; Michael Berk; Phyu P Aung; Ian C Lavery; Jean-Paul Achkar; Li Li; Graham Casey; Yan Xu
Plasma lysophosphatidylcholine levels: potential biomarkers for colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(19):2696-701.
2007: Toni K Choueiri; Brian I Rini; Jorge A Garcia; Rachid Baz; Rony M Abou-Jawde; Snehal G Thakkar; Paul Elson; Tarek Mekhail; M Zhou; Ronald M Bukowski
Prognostic factors associated with long-term survival in previously untreated metastatic renal cell carcinoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(2):249-55.
2007: Ena Segota; Tarek Mekhail; Thomas Olencki; Thomas E Hutson; Robert Dreicer; Brenda Wacker; Bruno Osterwalder; Paul Elson; Ming Zhou; Ronald M Bukowski
Phase II trial of capecitabine and rHu-interferon-alpha-2a in patients with metastatic renal cell carcinoma, limited efficacy, and moderate toxicity.
Urologic oncology 2007;25(1):46-52.
2006: Toni K Choueiri; Robert Dreicer; Brian I Rini; Paul Elson; Jorge A Garcia; Snehal G Thakkar; Rachid Baz; Tarek Mekhail; Holly A Jinks; Ronald M Bukowski
Phase II study of lenalidomide in patients with metastatic renal cell carcinoma.
Cancer 2006;107(11):2609-16.
2006: Snehal G Thakkar; David M Peereboom; Thomas Olencki; Barbara Jacobs; Paul Elson; Lisa Rybicki; Daniel J Lindner; Ernest C Borden
Short communication: phase I clinical and gene modulatory evaluation of tamoxifen and IFN-alpha2b.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2006;26(11):800-3.
2006: Revathi Suppiah; Laura Wood; Paul Elson; G Thomas Budd
Phase I/II study of docetaxel, ifosfamide, and doxorubicin in advanced, recurrent, or metastatic soft tissue sarcoma (STS).
Investigational new drugs 2006;24(6):509-14.
2006: Revathi Suppiah; Philip E Shaheen; Paul Elson; Seema A Misbah; Laura Wood; Robert J Motzer; Sylvie Negrier; Steven Andresen; Ronald M Bukowski
Thrombocytosis as a prognostic factor for survival in patients with metastatic renal cell carcinoma.
Cancer 2006;107(8):1793-800.
2006: Elisa Tso; Paul Elson; Fred Vanlente; Maurie Markman
The "real-life" variability of CA-125 in ovarian cancer patients.
Gynecologic oncology 2006;103(1):141-4.
2006: Tarek Mekhail; Hanspreet Kaur; Ram Ganapathi; G Thomas Budd; Paul Elson; Ronald M Bukowski
Phase 1 trial of Anvirzel in patients with refractory solid tumors.
Investigational new drugs 2006;24(5):423-7.
2006: Thomas Olencki; Sareena Malhi; Tarek Mekhail; Robert Dreicer; Paul Elson; Laura Wood; Ronald M Bukowski
Phase I trial of thalidomide and interleukin-2 in patients with metastatic renal cell carcinoma.
Investigational new drugs 2006;24(4):321-6.
2006: Navneet S Majhail; Laura Wood; Paul Elson; James Finke; Thomas Olencki; Ronald M Bukowski
Adjuvant subcutaneous interleukin-2 in patients with resected renal cell carcinoma: a pilot study.
Clinical genitourinary cancer 2006;5(1):50-6.
2006: Eric D Hsi; Stephen J Sup; Carlos Alemany; Elisa Tso; Marek Skacel; Paul Elson; Miguel A Alonso; Brad Pohlman
MAL is expressed in a subset of Hodgkin lymphoma and identifies a population of patients with poor prognosis.
American journal of clinical pathology 2006;125(5):776-82.
2006: Robert G Pretorius; Robert J Kim; Jerome Belinson; Paul Elson; You-Lin Qiao
Inflation of sensitivity of cervical cancer screening tests secondary to correlated error in colposcopy.
Journal of lower genital tract disease 2006;10(1):5-9.
2005: Philip E Shaheen; Walter Stadler; Paul Elson; Jennifer Knox; Eric Winquist; Ronald M Bukowski
Phase II study of the efficacy and safety of oral GD0039 in patients with locally advanced or metastatic renal cell carcinoma.
Investigational new drugs 2005;23(6):577-81.
2005: David Weng; Paul Masci; Susan F Radka; T Elise Jackson; Patricia A Weiss; Ram Ganapathi; Paul Elson; William B Capra; Vann P Parker; Jennifer A Lockridge; J Wayne Cowens; Nassim Usman; Ernest C Borden
A phase I clinical trial of a ribozyme-based angiogenesis inhibitor targeting vascular endothelial growth factor receptor-1 for patients with refractory solid tumors.
Molecular cancer therapeutics 2005;4(6):948-55.
2005: Stephen J Sup; Carlos A Alemañy; Brad Pohlman; Paul Elson; Sareena Malhi; Snehal G Thakkar; Roxanne Steinle; Eric D Hsi
Expression of bcl-2 in classical Hodgkin's lymphoma: an independent predictor of poor outcome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(16):3773-9.
2005: Robert Dreicer; Eric A Klein; Paul Elson; David M Peereboom; Tatiana V Byzova; Edward F Plow
Phase II trial of GM-CSF + thalidomide in patients with androgen-independent metastatic prostate cancer.
Urologic oncology 2005;23(2):82-6.
2005: Tarek Mekhail; Rony M Abou-Jawde; Gabriel Boumerhi; Sareena Malhi; Laura Wood; Paul Elson; Ronald Bukowski
Validation and extension of the Memorial Sloan-Kettering prognostic factors model for survival in patients with previously untreated metastatic renal cell carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(4):832-41.
2004: Lee M Akst; James Chan; Paul Elson; Jerrold Saxton; Marshall Strome; David J Adelstein
Functional outcomes following chemoradiotherapy for head and neck cancer.
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 2004;131(6):950-7.
2004: Navneet S Majhail; Mohamad Hussein; Thomas Olencki; G Thomas Budd; Laura Wood; Paul Elson; Ronald M Bukowski
Phase I trial of continuous infusion recombinant human interleukin-4 in patients with cancer.
Investigational new drugs 2004;22(4):421-6.
2004: Ronald M Bukowski; Sylvie Negrier; Paul Elson
Prognostic factors in patients with advanced renal cell carcinoma: development of an international kidney cancer working group.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(18 Pt 2):6310S-4S.
2004: Thomas E Hutson; Ram Ganapathi; Paul Elson; Tarek Mekhail; Thomas Olencki; G Thomas Budd; Ronald M Bukowski
Phase I trial of vinorelbine and diphenylhydantoin in patients with refractory carcinoma.
Investigational new drugs 2004;22(3):277-84.
2004: Gheath Alatrash; Thomas E Hutson; Luis Molto; Amy L Richmond; Cheryl Nemec; Tarek Mekhail; Paul Elson; Charles S Tannenbaum; Thomas Olencki; James Finke; Ronald M Bukowski
Clinical and immunologic effects of subcutaneously administered interleukin-12 and interferon alfa-2b: phase I trial of patients with metastatic renal cell carcinoma or malignant melanoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(14):2891-900.
2003: Tarek Mekhail; Rika Kawanishi-Tabata; Raymond Tubbs; Andrew C Novick; Paul Elson; Ram Ganapathi; Mahrukh K Ganapathi; Ronald Bukowski
Renal cell carcinoma (RCC) and telomerase activity: relationship to stage.
Urologic oncology 2003;21(6):424-30.
2003: Navneet S Majhail; Jean-Luc Urbain; Justin M Albani; Mangesh H Kanvinde; Thomas W Rice; Andrew C Novick; Tarek Mekhail; Thomas Olencki; Paul Elson; Ronald M Bukowski
F-18 fluorodeoxyglucose positron emission tomography in the evaluation of distant metastases from renal cell carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(21):3995-4000.
2003: Thomas E Hutson; Luis Molto; Tarek Mekhail; Paul Elson; James Finke; Charles S Tannenbaum; Ernest C Borden; Robert Dreicer; Thomas Olencki; Ronald M Bukowski
Phase I trial of consensus interferon in patients with metastatic renal cell carcinoma: toxicity and immunological effects.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(4):1354-60.
2003: Navneet S Majhail; Paul Elson; Ronald M Bukowski
Therapy and outcome of small cell carcinoma of the kidney: report of two cases and a systematic review of the literature.
Cancer 2003;97(6):1436-41.
2003: ali chahlavi; Andrew Kanner; David M Peereboom; Susan M Staugaitis; Paul Elson; Gene Barnett
Impact of chromosome 1p status in response of oligodendroglioma to temozolomide: preliminary results.
Journal of neuro-oncology 2003;61(3):267-73.
2003: Aleck A Hercbergs; Lav K Goyal; John H Suh; Sy Lee; Chandana A Reddy; Bruce Howard Cohen; Glen H J Stevens; Sethu K Reddy; David M Peereboom; Paul Elson; Manjula K Gupta; Gene H Barnett
Propylthiouracil-induced chemical hypothyroidism with high-dose tamoxifen prolongs survival in recurrent high grade glioma: a phase I/II study.
Anticancer research 2003;23(1B):617-26.
2003: Tarek Mekhail; Thomas E Hutson; Paul Elson; G Thomas Budd; Gordan Srkalovic; Thomas Olencki; David M Peereboom; Robert Pelley; Ronald M Bukowski
Phase I trial of weekly docetaxel and gemcitabine in patients with refractory malignancies.
Cancer 2003;97(1):170-8.
2002: Mohamad A Hussein; Laura Wood; Eric D Hsi; Gordan Srkalovic; Mary Ann Karam; Paul Elson; Ronald M Bukowski
A Phase II trial of pegylated liposomal doxorubicin, vincristine, and reduced-dose dexamethasone combination therapy in newly diagnosed multiple myeloma patients.
Cancer 2002;95(10):2160-8.
2002: Rika Kawanishi-Tabata; Francisco Lopez; Sam Fratantonio; Nam Kim; John R Goldblum; Raymond Tubbs; Paul Elson; Ian C Lavery; Ronald M Bukowski; Ram Ganapathi; Mahrukh K Ganapathi
Telomerase activity in stage II colorectal carcinoma.
Cancer 2002;95(9):1834-9.
2002: F Perez-Zincer; Thomas Olencki; G Thomas Budd; David M Peereboom; Paul Elson; Ronald M Bukowski
A phase I trial of weekly gemcitabine and subcutaneous interferon alpha in patients with refractory renal cell carcinoma.
Investigational new drugs 2002;20(3):305-10.
2002: Xing-Yue He; Paul Elson; Brad Pohlman; Alan E Lichtin; Mohamad Hussein; Steven Andresen; Matt Kalaycio
Timed sequential chemotherapy with concomitant granulocyte colony-stimulating factor for high-risk acute myelogenous leukemia: a single arm clinical trial.
BMC cancer 2002;2():12.
2002: Jerome Belinson; Qin-jing Pan; Charles V Biscotti; Ling-ying Wu; Robert G Pretorius; Ling Li; Paul Elson; Shou-de Rong; Wen-hua Zhang; You-Lin Qiao
Primary screening with liquid-based cytology in an unscreened population in rural China, with an emphasis on reprocessing unsatisfactory samples.
Acta cytologica 2002;46(3):470-4.
2002: Gordan Srkalovic; Paul Elson; Beth Trebisky; Mary Ann Karam; Mohamad A Hussein
Use of melphalan, thalidomide, and dexamethasone in treatment of refractory and relapsed multiple myeloma.
Medical oncology (Northwood, London, England) 2002;19(4):219-26.
2001: Jerome Belinson; You-Lin Qiao; Robert G Pretorius; Wen-hua Zhang; Paul Elson; Ling Li; Qin-jing Pan; C Fischer; A Lorincz; D Zahniser
Shanxi Province Cervical Cancer Screening Study: a cross-sectional comparative trial of multiple techniques to detect cervical neoplasia.
Gynecologic oncology 2001;83(2):439-44.
2001: M A Hussein; Kate Wakeling; Paul Elson; James Finke; D McLain; Patricia Rayman; L A Rybicki; R A Bukowski
GM-CSF safety and effects in the management of advanced/refractory multiple myeloma patients: a phase I trial.
Journal of cancer research and clinical oncology 2001;127(10):619-24.
2001: Z Shen; M Wu; Paul Elson; Alexander W Kennedy; Jerome Belinson; Graham Casey; Yan Xu
Fatty acid composition of lysophosphatidic acid and lysophosphatidylinositol in plasma from patients with ovarian cancer and other gynecological diseases.
Gynecologic oncology 2001;83(1):25-30.
2001: Jerome Belinson; Robert G Pretorius; Wen-hua Zhang; Ling-ying Wu; You-Lin Qiao; Paul Elson
Cervical cancer screening by simple visual inspection after acetic acid.
Obstetrics and gynecology 2001;98(3):441-4.
2001: Robert G Pretorius; Jerome Belinson; Wen-hua Zhang; Raoul J Burchette; Paul Elson; You-Lin Qiao
The colposcopic impression. Is it influenced by the colposcopist's knowledge of the findings on the referral Papanicolaou smear?
The Journal of reproductive medicine 2001;46(8):724-8.
2001: Susan A J Vaziri; Lisa M Krumroy; Paul Elson; G Thomas Budd; G Darlington; J Myles; Raymond R Tubbs; Graham Casey
Breast tumor immunophenotype of BRCA1-mutation carriers is influenced by age at diagnosis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(7):1937-45.
2001: Thomas Olencki; David M Peereboom; Laura Wood; G Thomas Budd; Andrew C Novick; James Finke; D McLain; Paul Elson; Ronald M Bukowski
Phase I and II trials of subcutaneously administered rIL-2, interferon alfa-2a, and fluorouracil in patients with metastatic renal carcinoma.
Journal of cancer research and clinical oncology 2001;127(5):319-24.
2001: Matt Kalaycio; Brad Pohlman; Paul Elson; Alan E Lichtin; Mohamad Hussein; B Tripp; Steven Andresen
Chemotherapy for acute myelogenous leukemia in the elderly with cytarabine, mitoxantrone, and granulocyte-macrophage colony-stimulating factor.
American journal of clinical oncology 2001;24(1):58-63.
2000: Thomas Olencki; James Finke; Raymond Tubbs; Paul Elson; D McLain; P Herzog; G Thomas Budd; H Gunn; Ronald M Bukowski
Phase 1 trial of subcutaneous IL-6 in patients with refractory cancer: clinical and biologic effects.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2000;23(5):549-56.
2000: T Chidiac; G Thomas Budd; Robert Pelley; Kate Wakeling; D McLain; Paul Elson; Richard L Crownover; Kenneth E Marks; George F Muschler; Michael Joyce; Robert J Zehr; Ronald Bukowski
Phase II trial of liposomal doxorubicin (Doxil) in advanced soft tissue sarcomas.
Investigational new drugs 2000;18(3):253-9.
2000: Rosalind U van Stolk; G Stoner; W L Hayton; K Chan; B DeYoung; Laura Kresty; B H Kemmenoe; Paul Elson; Lisa Rybicki; James Church; KS Provencher; D McLain; Ernest T Hawk; BH Fryer; Gary J Kelloff; Ram Ganapathi; G Thomas Budd
Phase I trial of exisulind (sulindac sulfone, FGN-1) as a chemopreventive agent in patients with familial adenomatous polyposis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(1):78-89.
1999: Gary D Stoner; G Thomas Budd; Ram Ganapathi; B DeYoung; Laura Kresty; M Nitert; BH Fryer; James M Church; KS Provencher; Rifat Pamukcu; Gary Piazza; Ernest T Hawk; Gary J Kelloff; Paul Elson; Rosalind U van Stolk
Sulindac sulfone induced regression of rectal polyps in patients with familial adenomatous polyposis.
Advances in experimental medicine and biology 1999;470():45-53.
1999: James Ulchaker; J Panuto; Patricia Rayman; Andrew C Novick; Paul Elson; Raymond Tubbs; James H Finke; Ronald M Bukowski
Interferon-gamma production by T lymphocytes from renal cell carcinoma patients: evidence of impaired secretion in response to interleukin-12.
Journal of immunotherapy (Hagerstown, Md. : 1997) 1999;22(1):71-9.
1998: Ronald M Bukowski; Patricia Rayman; Robert G Uzzo; T Bloom; Kate Wakeling; David M Peereboom; Thomas Olencki; G Thomas Budd; D McLain; Paul Elson; Andrew C Novick; James H Finke
Signal transduction abnormalities in T lymphocytes from patients with advanced renal carcinoma: clinical relevance and effects of cytokine therapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(10):2337-47.
1998: Yan Xu; Z Shen; D W Wiper; M Wu; Richard E Morton; Paul Elson; Alexander W Kennedy; Jerome Belinson; Maurie Markman; Graham Casey
Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers.
JAMA : the journal of the American Medical Association 1998;280(8):719-23.
1998: K Rajagopalan; David M Peereboom; G Thomas Budd; Thomas Olencki; S Murthy; Paul Elson; D McLain; Ronald Bukowski
Phase II trial of circadian infusion floxuridine (FUDR) in hormone refractory metastatic prostate cancer.
Investigational new drugs 1998;16(3):255-8.
1997: Ronald M Bukowski; Thomas Olencki; Q Wang; David M Peereboom; G Thomas Budd; Paul Elson; Kate Wakeling; L Tuason; Patricia Rayman; Raymond Tubbs; D McLain; E Klein; Andrew C Novick; James Finke
Phase II trial of interleukin-2 and interferon-alpha in patients with renal cell carcinoma: clinical results and immunologic correlates of response.
Journal of immunotherapy (Hagerstown, Md. : 1997) 1997;20(4):301-11.
1996: Ronald M Bukowski; Thomas Olencki; H Gunn; D McLain; G Thomas Budd; Kate Wakeling; L Tuason; C Redovan; Patricia Rayman; Raymond Tubbs; D Resta; Paul Elson; James Finke
Phase I trial of subcutaneous interleukin 3 in patients with refractory malignancy: hematological, immunological, and pharmacodynamic findings.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(2):347-57.